Advertisement
ALHC vs UNH
Which Stock Would AI Choose? Alignment Healthcare (ALHC) vs. UnitedHealth Group (UNH) Stock Comparison
Key Takeaways
- ALHC is a fast-growing, technology-enabled Medicare Advantage (privately administered Medicare) insurer for seniors, while UNH is the largest diversified U.S. healthcare company, spanning insurance and health services.
- The two operate at vastly different scales: UNH carries a market capitalization measured in the hundreds of billions of dollars, while ALHC is a smaller, higher-growth name with a multibillion-dollar valuation.
- Recent market activity has diverged sharply — UNH has gained momentum on margin recovery, whereas ALHC has faced volatility tied to rising medical costs and headline-driven sentiment shifts.
- UNH is executing a profitability-focused turnaround with an improving medical care ratio, while ALHC is balancing rapid membership growth against near-term execution and cost pressures.
- The relative performance gap reflects a contrast between a mature margin-recovery story and an early-stage growth story still proving its path to durable profitability.
Introduction
Comparing ALHC and UNH places two very different healthcare business models side by side. Alignment Healthcare is a focused Medicare Advantage insurer targeting seniors with a data-driven care platform, while UnitedHealth Group is a diversified healthcare giant whose UnitedHealthcare and Optum businesses span insurance, care delivery, and pharmacy services. This stock comparison is most relevant to investors weighing high-growth, higher-volatility exposure against a larger, more established franchise undergoing a margin-recovery turnaround. The contrast in scale, growth trajectory, and recent market positioning offers a useful lens for understanding how sentiment and relative performance can diverge even within the same broad healthcare sector.
ALHC Overview and Recent Performance
ALHC (Alignment Healthcare) operates a consumer-centric Medicare Advantage platform for seniors in the United States, founded in 2013 and headquartered in Orange, California. The company has posted rapid revenue and membership growth, and in recent quarters it transitioned from net losses toward modest profitability while raising its full-year outlook.
Recent market activity, however, has been marked by pronounced volatility. Over recent weeks and months the stock has pulled back sharply, weighed down by concerns about rising hospital and skilled-nursing costs, a claims-system transition, and regulatory headlines including securities-related investigations and questions around Medicare star ratings. These developments have overshadowed the company's underlying membership gains and technology investments, contributing to a meaningful decline in its share price and a weakening of near-term momentum relative to its 52-week highs. The narrative now centers on whether growth and automation-driven efficiency can translate into sustained, durable profitability amid shifting Medicare reimbursement dynamics.
UNH Overview and Recent Performance
UNH (UnitedHealth Group) is the largest U.S. health insurer and a diversified healthcare leader, operating the UnitedHealthcare insurance arm alongside Optum, which provides care delivery, technology, and pharmacy benefit services. After a difficult 2025 that included elevated medical costs and regulatory headwinds, the company has been executing a turnaround focused on pricing discipline, cost control, and portfolio optimization.
Recent results have strengthened investor confidence. In its latest quarterly report, UnitedHealth beat earnings expectations and raised its full-year adjusted earnings guidance, aided by an improving medical care ratio — the share of each premium dollar spent on medical claims — which declined year over year. The Optum Health unit also showed a notable rebound in operating earnings. At the same time, the company has deliberately reduced membership in less profitable lines, prioritizing margins over enrollment growth. This margin-first approach has supported a recovery in the stock's relative performance, even as commercial medical-cost trends and an ongoing regulatory environment remain key watch items.
Trending AI Robots
Tickeron's Trending AI Robots page curates a focused selection of AI-powered trading bots drawn from a much larger library of hundreds of automated systems that trade thousands of different tickers. Because each bot operates with its own trading style, strategy, timeframe, performance history, statistics, and set of securities, only those best suited to current market conditions earn a place in this featured section. This curated view helps traders identify algorithmic strategies whose approaches align with the prevailing market environment, whether that environment favors momentum, mean reversion, or trend-following logic. Readers interested in seeing how machine-driven analysis currently ranks names like those discussed here can explore the Trending AI Robots section directly.
Head-to-Head Comparison
These two companies diverge across nearly every key dimension. On business model, ALHC is a concentrated Medicare Advantage growth story, while UNH is a diversified healthcare enterprise with multiple revenue streams, including the Optum health-services platform. On growth drivers, ALHC leans on membership expansion and automation-driven operating leverage, whereas UNH is currently emphasizing margin recovery and cost discipline over enrollment growth.
The recent momentum gap is notable: UNH has enjoyed a relative improvement in sentiment supported by consecutive guidance raises, while ALHC has faced a sharp drawdown driven by medical-cost and headline pressures. In terms of risk factors, ALHC carries execution, reimbursement, and regulatory-investigation risks typical of a rapidly scaling insurer, while UNH faces commercial medical-cost trends, Medicaid margin pressure, and ongoing regulatory scrutiny at a much larger scale. Finally, market positioning differs in kind — one is a smaller, higher-beta name sensitive to single-quarter outcomes, while the other offers broader diversification and greater stability in its cash flows and capital returns.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would currently lean toward UNH over ALHC. The reasoning centers on trend consistency and relative positioning: UnitedHealth has displayed more stable, improving momentum supported by consecutive earnings beats, rising guidance, and a recovering medical cost ratio, whereas Alignment Healthcare's recent price action has been characterized by elevated volatility and a weakening short-term trend amid medical-cost and regulatory headlines. While ALHC's growth profile and automation initiatives offer a distinct long-term catalyst set, its near-term positioning is less favorable on a relative basis. This assessment is probabilistic rather than definitive and reflects current trend, stability, and catalyst dynamics rather than a forecast of future returns.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALHC is a Hold and UNH is a StrongBuy.
ALHC's RSI Oscillator recovers from oversold territory
The RSI Oscillator for ALHC moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ALHC just turned positive on October 02, 2026. Looking at past instances where ALHC's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.
Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALHC advanced for three days, in 249 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALHC as a result. In 72 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ALHC entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ALHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 84 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALHC's P/B Ratio (6.596) is slightly higher than the industry average of (3.582). P/E Ratio (42.150) is within average values for comparable stocks, (130.390). ALHC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.389) is also within normal values, averaging (0.569).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
UNH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for UNH turned positive on October 05, 2026. Looking at past instances where UNH's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on UNH as a result. In 46 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 182 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UNH entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating fairly steady price growth. UNH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.875) is normal, around the industry mean (3.582). P/E Ratio (27.242) is within average values for comparable stocks, (130.390). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.022) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
UNH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | |
PROFIT vs RISK RATING 1..100 | 89 | |
SMR RATING 1..100 | 58 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ALHC | UNH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 58% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 89% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 55% |
| Advances ODDS (%) | 3 days ago 82% | 3 days ago 55% |
| Declines ODDS (%) | 1 day ago 84% | 10 days ago 53% |
| BollingerBands ODDS (%) | N/A | 1 day ago 52% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 56% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALHC’s FA Score shows that 0 FA rating(s) are green while UNH’s FA Score has 1 green FA rating(s).
- ALHC’s FA Score: 0 green, 5 red.
- UNH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALHC’s TA Score shows that 3 TA indicator(s) are bullish while UNH’s TA Score has 5 bullish TA indicator(s).
- ALHC’s TA Score: 3 bullish, 4 bearish.
- UNH’s TA Score: 5 bullish, 5 bearish.
Price Growth
ALHC (@Managed Health Care) experienced а +3.44% price change this week, while UNH (@Managed Health Care) price change was +4.50% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +2.49%. For the same industry, the average monthly price growth was +10.42%, and the average quarterly price growth was +42.97%.
Reported Earning Dates
ALHC is expected to report earnings on Oct 29, 2026.
UNH is expected to report earnings on Jan 20, 2027.
Industries' Descriptions
@Managed Health Care (+2.49% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
Advertisement
ALHC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALHC has been loosely correlated with UNH. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALHC jumps, then UNH could also see price increases.
| Ticker / NAME | Correlation To ALHC | 1D Price Change % | ||
|---|---|---|---|---|
| ALHC | 100% | -0.12% | ||
| UNH - ALHC | 40% Loosely correlated | +1.91% | ||
| CLOV - ALHC | 35% Loosely correlated | -1.05% | ||
| HUM - ALHC | 33% Loosely correlated | -1.05% | ||
| CVS - ALHC | 32% Poorly correlated | +1.83% | ||
| CI - ALHC | 30% Poorly correlated | +3.78% | ||
More | ||||
UNH and
Correlation & Price change
A.I.dvisor indicates that over the last year, UNH has been closely correlated with ELV. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if UNH jumps, then ELV could also see price increases.